Cargando…

Biology of MiR-17-92 Cluster and Its Progress in Lung Cancer

MicroRNAs, a class of short endogenous RNAs, acting as post-transcriptional regulators of gene expression, mostly silence gene expression via binding imperfectly matched sequences in the 3'UTR of target mRNA. MiR-17-92, a highly conserved gene cluster, has 6 members including miR-17, miR-18a, m...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xinju, Li, Yanli, Qi, Pengfei, Ma, Zhongliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6216058/
https://www.ncbi.nlm.nih.gov/pubmed/30443163
http://dx.doi.org/10.7150/ijms.27341
_version_ 1783368270870478848
author Zhang, Xinju
Li, Yanli
Qi, Pengfei
Ma, Zhongliang
author_facet Zhang, Xinju
Li, Yanli
Qi, Pengfei
Ma, Zhongliang
author_sort Zhang, Xinju
collection PubMed
description MicroRNAs, a class of short endogenous RNAs, acting as post-transcriptional regulators of gene expression, mostly silence gene expression via binding imperfectly matched sequences in the 3'UTR of target mRNA. MiR-17-92, a highly conserved gene cluster, has 6 members including miR-17, miR-18a, miR-19a, miR-20a, miR-19b-1 and miR-92a. The miR-17-92 cluster, regarded as oncogene, is overexpressed in human cancers. Lung cancer is the leading cause of death all over the world. The molecular mechanism of lung cancer has been partly known at the levels of genes and proteins in last decade. However, new prognosis biomarkers and more target drugs should be developed in future. Therefore, noncoding RNAs, especially miRNAs, make them as new potentially clinical biomarkers for diagnosis and prognosis. In this review, we focus the current progress of miR-17-92 cluster in lung cancer.
format Online
Article
Text
id pubmed-6216058
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-62160582018-11-15 Biology of MiR-17-92 Cluster and Its Progress in Lung Cancer Zhang, Xinju Li, Yanli Qi, Pengfei Ma, Zhongliang Int J Med Sci Review MicroRNAs, a class of short endogenous RNAs, acting as post-transcriptional regulators of gene expression, mostly silence gene expression via binding imperfectly matched sequences in the 3'UTR of target mRNA. MiR-17-92, a highly conserved gene cluster, has 6 members including miR-17, miR-18a, miR-19a, miR-20a, miR-19b-1 and miR-92a. The miR-17-92 cluster, regarded as oncogene, is overexpressed in human cancers. Lung cancer is the leading cause of death all over the world. The molecular mechanism of lung cancer has been partly known at the levels of genes and proteins in last decade. However, new prognosis biomarkers and more target drugs should be developed in future. Therefore, noncoding RNAs, especially miRNAs, make them as new potentially clinical biomarkers for diagnosis and prognosis. In this review, we focus the current progress of miR-17-92 cluster in lung cancer. Ivyspring International Publisher 2018-09-07 /pmc/articles/PMC6216058/ /pubmed/30443163 http://dx.doi.org/10.7150/ijms.27341 Text en © Ivyspring International Publisher This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Review
Zhang, Xinju
Li, Yanli
Qi, Pengfei
Ma, Zhongliang
Biology of MiR-17-92 Cluster and Its Progress in Lung Cancer
title Biology of MiR-17-92 Cluster and Its Progress in Lung Cancer
title_full Biology of MiR-17-92 Cluster and Its Progress in Lung Cancer
title_fullStr Biology of MiR-17-92 Cluster and Its Progress in Lung Cancer
title_full_unstemmed Biology of MiR-17-92 Cluster and Its Progress in Lung Cancer
title_short Biology of MiR-17-92 Cluster and Its Progress in Lung Cancer
title_sort biology of mir-17-92 cluster and its progress in lung cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6216058/
https://www.ncbi.nlm.nih.gov/pubmed/30443163
http://dx.doi.org/10.7150/ijms.27341
work_keys_str_mv AT zhangxinju biologyofmir1792clusteranditsprogressinlungcancer
AT liyanli biologyofmir1792clusteranditsprogressinlungcancer
AT qipengfei biologyofmir1792clusteranditsprogressinlungcancer
AT mazhongliang biologyofmir1792clusteranditsprogressinlungcancer